Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2022-11-12 Capital/Financing Update
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the conversion of debt into shares by PreveCeutical Medical Inc. It details the assignment agreement and conversion terms but does not contain financial statements, detailed financial performance data, or comprehensive financial analysis. It is an update on a financing-related transaction involving convertible debt and share issuance. There is no indication that this is a full financial report, audit, or earnings release. The content fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through debt conversion into equity shares.
2022-11-12 English
News release - English.pdf
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement regarding the monthly distribution amount and payment date for Dream Residential REIT. It specifies the distribution amount for October 2022 and the payable date, which is typical of dividend or distribution announcements. The document length is only 1202 characters, indicating it is a brief notice rather than a detailed financial report. There is no detailed financial data, management discussion, or comprehensive report content. Therefore, this fits the category of a Notice of Dividend Amount (DIV).
2022-10-20 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of Kathleen Rotika to the company's board of directors. It focuses on management changes and does not contain financial statements, audit information, or detailed financial data. The content is about a change in the board composition, which fits the category of Board/Management Information (MANG). The document length is 6751 characters, which is sufficient for a detailed announcement but does not constitute a full report like an annual or interim report. There is no indication that this is a report or regulatory filing but rather a management announcement.
2022-10-20 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing the resignation of a member of the company's board of directors. It specifically states the resignation of Mr. Sachin Nanavati from the Board of PreveCeutical Medical Inc. There is no financial data, no mention of a report or financial results, and the content focuses solely on a change in the board membership. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is sufficient and the content is clearly about management changes, not a report or other filing type.
2022-09-17 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document announces the appointment of a new member to the company's board of directors, including biographical details and statements from the CEO and the appointee. There is no financial data, no mention of financial results, no regulatory filings, or other report types. The content is focused on management changes at the board level. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and the content is clearly about management changes, not a report or announcement of a report.
2022-09-06 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-08-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.